Health Tech | Health IT to promote self-care, individual responsibility | News

A new and popular wave of technology used in healthcare in the last decade or so is personal remote-care devices such as fitness trackers. This started an increase in the development of wellness apps and more involvement by persons in their health and well-being.

Since then, the healthcare IT industry has grown exponentially, and types of remote-care devices have been on the increase and incorporated into hospital and practice- management systems to create more holistic healthcare, with access from anywhere. This also enabled health professionals and organisations to be able to serve more people, including those who are immobile or can be better monitored through at-home care.

Remote-care devices span a large variety of health categories for which indices can be checked and monitored, including diabetes, heart conditions, blood pressure, mental health, and much more. They are a good way of keeping medical professionals abreast of the progress and constant condition of a patient even when they are not actively consulting.

Most hospital and practice-management systems can incorporate these indices into patients’ electronic medical records so that a history of their condition can easily be seen and used to track their progress, make decisions as to how best they should be treated, and assist them with prevention initiatives.

It is also a good way for people to self-track and make the lifestyle changes required to maintain good health. With the increased adaptation of e-health globally, there has been another push for remote=care devices to be used by individuals, but now also through their healthcare provider to promote individual responsibility, self-care and increased involvement in their ongoing health and well=being.

Self-care with respect to health, according to the World Health Organization (WHO), “is the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and cope with illness

Read the rest Read More

WELL Health joins Digital Technology Supercluster Project to Advance Interoperability and Leverage AI to Reduce Provider Burdens

VANCOUVER, BC, Jan. 13, 2023 /CNW/ – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company“), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce it has partnered with ORX Surgical (“ORX“), Tali AI (“Tali“), and Simon Fraser University (“SFU“) to transform healthcare data into actionable insights through a Digital Technology Supercluster (“DTS“) project called Health Compass.

There has historically been large amounts of data locked in outdated and inefficient electronic medical records (“EMR“) that have proven to be a major cause of burnout for physicians. Sorting through massive amounts of data takes a physician’s time away from delivering care to their patients. Health Compass applies artificial intelligence to existing EMRs, helping physicians find the insights they need, and make critical decisions faster for their patients. Health Compass offers a natural voice interface that recognizes physicians’ voices to streamline clinical documentation and queries for patients, applies predictive analytics to help flag high-need patients, and automates the patient journey in primary care and specialty care to connect patients with life changing care quickly.

WELL and its internal several subsidiaries participating in the project (AwareMD, OSCAR Pro, Intrahealth, Ocean, Doctorcare, apps.health) have secured $3M in co-investment funding from DTS to support WELL’s platform which will be used to pilot the Health Compass project. More specifically, the project will leverage and build upon WELL’s open and FHIR-based apps.health ecosystem to seamlessly integrate the Health Compass capabilities into the EMR. The funding will also be used enhance the ability for digital health innovations to interoperate with EMRs and make it easier for providers to augment their EMR with the latest innovations

Read the rest Read More

MRO Enhances Executive Leadership Team with Two Healthcare Technology Veteran Hires

Matt Wildman, Chief Commercial Officer, and Moliehi Weitnauer, Chief Product Officer, join MRO to help drive growth and innovation

NORRISTOWN, Pa., Jan. 23, 2023 /PRNewswire/ — MRO, Corp. (MRO), the leading clinical data exchange platform in healthcare, announced today two key additions to the executive leadership team. Matt Wildman has joined as Chief Commercial Officer and Moliehi (Mo) Weitnauer as Chief Product Officer. MRO’s enhanced leadership team brings deep expertise in clinical data circulation and a shared passion to transform the clinical data exchange for providers, payers, and users of clinical data.

Weitnauer enjoys a robust skillset in product strategy and product management, having helped build product organizations for many leading companies. Most recently, she did so at Cotiviti, where she was senior vice president of corporate and product strategy, and FinThrive, where she led product management for the billing and denials management solutions portfolio.

“Clinical data exchange is a core challenge in the healthcare industry. MRO is at the epicenter of this industry challenge and is positioned to continue to bring unique enterprise clinical data exchange solutions to the market,” said Weitnauer. “I’m excited to join a company with deep expertise and advanced technology in clinical data exchange and I’m looking forward to driving innovation and helping shape the portfolio of solutions into the future,” she continued.

Wildman brings a wealth of experience with clinical data and technology. Prior to joining MRO, Wildman spent 20 years with Cerner Corporation in a variety of roles, including general manager of Cerner Australia, head of sales, and senior vice president of client relationships. In Wildman’s new role as chief commercial officer, he is accountable for MRO’s go-to-market strategies, market expansion, and creating deeper alignment with current and prospective clients.

“Healthcare providers are overwhelmed with requests for clinical data, a

Read the rest Read More

Top 10 Health Technology Hazards in 2023 to Watch

Top 10 Health Technology Hazards for 2023

What You Should Know:

ECRI, the nation’s largest non-profit patient safety organization, names communications gaps with recalls of home-use medical devices as the nation’s most pressing health technology safety issue for 2023.

ECRI’s Top 10 Health Technology Hazards for 2023 list identifies the potential sources of danger that will warrant the greatest attention for the coming year and offers practical recommendations for reducing risks. 

Top 10 Health Technology Hazards for 2023

For 2023, ECRI’s report includes a series of challenges to industry, urging manufacturers to pursue device or process improvements that could mitigate—or even eliminate—some of the hazards included on the list. With healthcare facilities understaffed and healthcare workers overstressed, it’s more important than ever that technologies be designed in ways that ensure their safe use.

The 10 topics on ECRI’s 2023 hazards list are listed below in rank order:

1. Gaps in Recalls for At-Home Medical Devices cause patient confusion and harm

Accurate and understandable information about medical device recalls often does not reach patients using those devices in the home; this information gap is growing every year as healthcare moves into the home setting.

2. Growing Number of Defective Single-Use Medical Devices puts patients at risk

An unacceptably high number of defective single-use medical devices continue to be present in the supply chain. Single-use medical devices—which include products that are used once and then discarded, as well as those that get consumed during use—play a role in virtually every patient encounter. As a result, defective products can have a broad, negative impact on patient care, causing delays and increasing costs—and most concerningly, contributing to patient harm or death in some circumstances.

3. Inappropriate Use of Automated Dispensing Cabinet Overrides can result in medication errors

Automated dispensing cabinets (ADCs) are used to provide controlled access to

Read the rest Read More

How Nanobodies Could Be a Big Game Changer for Plant Health Technology

On Christmas Eve 2020, a group of scientists released a report on a revolutionary new method for battling COVID-19. As a couple of ag researchers read through the findings, they became more and more excited. The potential of the described technology seemed almost limitless. Nanobodies, a tiny piece of the antibody cells found in the camelid animal family (camels, llamas, and so on), could interfere with just about any cellular organism, including bacteria and viruses.

One of those scientists reading the study results was Michelle Heck, PhD, Emerging Pests and Pathogens Research Molecular Biologist, USDA-ARS, who quickly reached out to her Florida colleagues, Robert Shatters, PhD, Research Molecular Biologist, USDA-ARS, and Marco Pitino, Lead Project Scientist at AgroSource. They were leading a team trying to find a way to battle citrus greening.

Heck, Shatters, and Pitino set out to do the following: See if plants and symbionts could produce nanobodies against COVID-19 and citrus greening disease, and find a cost-effective way to deliver nanobodies to trees to fight against the disease.

The trio recently released their own study showing proof of concept for these ideas.

Naturally, I had a lot of questions on nanobodies. Here is a small part of a Q&A with Heck and Shatters.

Why There’s Much to Learn from Italian Fruit Growers’ Rock-Solid Approach

How do nanobodies work?

Heck: [In citrus greening], the bacteria express these little weapons proteins called effector molecules/ effector proteins. [An effector molecule is a small molecule that selectively binds to host molecules and regulates their biological activity and this activity can induce disease symptoms.]

If the bacterial infection starts here in the plant or on this leaf, the bacteria will secrete effector proteins that move to the other part of the plant to dampen the plant’s immune system

Read the rest Read More